ATP depletion as a consequence of adenosine deaminase inhibition in man.
ATP depletion as a consequence of adenosine deaminase inhibition in man.
复制标题
人类腺苷脱氨酶抑制导致 ATP 耗竭。
DOI:
10.1073/pnas.77.10.6157
复制
发表时间:
1980
影响因子:
11.1
通讯作者:
Hutton,JJ
中科院分区:
文献类型:
--
作者:
Siaw,MF;Mitchell,BS;Koller,CA;Coleman,MS;Hutton,JJ
Hereditary deficiency of the enzyme adenosie deaminase (adenosine aminohydrolase, EC 3.5.4.4) results in an immunodeficiency syndrome characterized by a marked reduction in circulating lymphocytes. We have administered 2'-deoxycoformycin, a potent inhibitor of adenosine deaminase, to a patient with a lymphoproliferative malignancy. The clinical consequences of pharmacologic inhibition of adenosine deaminase activity included an abrupt decrease in the lymphocyte count, abnormalities of renal and hepatic function, and hemolytic anemia. The plasma concentrations of adenosine and deoxyadenosine rose to peak values of 13 microM and 5 microM, respectively, and erythrocyte dATP levels increased to 110 pmol/10(6) cells over 9 days. There was a corresponding decrease in erythrocyte ATP levels from 128 to < 6 pmol/10(6) cells. A similar profound reductin in ATP occurred in the erythrocytes of a second patient. The rapid and unexpected depletion of ATP associated with dATP accumulation may account, at least in part, for the toxicity associated with 2'-deoxycoformycin administration. The inverse relationship of ATP and dATP raises major questions about the control of energy metabolism in erythrocytes.